Top Abstract Purchase Related
Home
>
Node
>
Subnode

Clinical impact of combination antiretroviral therapy

Gatanaga, H.

Nihon Rinsho. Japanese Journal of Clinical Medicine 60(4): 739-744

2002

ISSN/ISBN: 0047-1852
PMID: 11968781
Document Number: 550719
After the advent of HIV protease inhibitor in 1995, the clinical feature of HIV disease has been dramatically changed. Combination antiretroviral therapy containing protease inhibitor can suppress the viral load under the detection limit and recover the immune status in HIV-infected individuals. However, it still seems impossible to eradicate the viruses from infected individuals. They will have to continue the combination therapy for life with good compliance because incomplete viral suppression induces the resistant viruses. The clinical feature of opportunistic infections in HIV-infected patients has also been changed. In some cases, prophylaxes for Pneumocystis carinii pneumonia and Mycobacterium avium complex infections are not necessary after the introduction of combination antiretroviral therapy.

Document emailed within 1 workday
Secure & encrypted payments

Fox, R.; Gourlay, Y.J. 2000: The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow Health Bulletin 58(4): 309-315
Kato, M.; Granich, R.; Bui, D.D.; Tran, H.V.; Nadol, P.; Jacka, D.; Sabin, K.; Suthar, A.B.; Mesquita, F.; Lo, Y.Ru.; Williams, B. 2013: The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: towards elimination of HIV transmission Journal of Acquired Immune Deficiency Syndromes 63(5): E142-E149
Bailey, H.; Townsend, C.L.; Semenenko, I.; Malyuta, R.; Cortina-Borja, M.; Thorne, C.; Pilipenko, T.; Zayats, A.; Posokhova, S.; Kaleeva, T.; Barishnikova, Y.; Servetsky, S.; Teretsenko, R.; Stelmah, A.; Kiseleva, G.; Dotsenko, E.; Zalata, O.A.; Solokha, S.; Grazhdanov, M.P.; Kulakovskaya, E.; Bashkatova, N.; Gigil, V.; Raus, I.; Yurchenko, O.V.; Adeyanova, I.; Ruban, Z.; Govorun, O.; Ostrovskaya, O.; Kochergina, I.; Kvasha, L.; Kruglenko, G.; Primak, N. 2013: Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine Bulletin of the World Health Organization 91(7): 491-500
Pasquet, A.; Messou, E.èn.; Gabillard, D.; Minga, A.; Depoulosky, A.; Deuffic-Burban, S.; Losina, E.; Freedberg, K.A.; Danel, C.; Anglaret, X.; Yazdanpanah, Y. 2010: Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire Plos one 5(10): E13414
Kiboneka, A.; Wangisi, J.; Nabiryo, C.; Tembe, J.; Kusemererwa, S.; Olupot-Olupot, P.; Joffres, M.; Anema, A.; Cooper, C.L.; Montaner, J.S.; Mills, E.J. 2008: Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda Aids 22(18): 2493-2499
Kiwuwa-Muyingo, S.; Walker, A.S.; Oja, H.; Levin, J.; Miiro, G.; Katabira, E.; Kityo, C.; Hakim, J.; Todd, J.; Grosskurth, H.; Munderi, P.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Mugisha, A.; Todd, J.; Levin, J.; Muyingo, S.; Ruberantwari, A.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Lyagoba, F.; Hughes, P.; Aber, M.; Medina Lara, A.; Foster, S.; Amurwon, J.; Nyanzi Wakholi, B.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Fadhiru, K.; Nsibambi, D.; Khauka, P.; Mugyenyi, P.; Kityo, C.; Ssali, F.; Tumukunde, D.; Otim, T.; Kabanda, J.; Musana, H.; Akao, J.; Kyomugisha 2012: The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe Tropical Medicine and International Health: Tm and Ih 17(5): 584-594
Ouattara, E.N.; Ross, E.L.; Yazdanpanah, Y.; Wong, A.Y.; Robine, M.; Losina, E.; Moh, R.; Walensky, R.P.; Danel, C.; Paltiel, A.D.; Eholié, S.P.; Freedberg, K.A.; Anglaret, X. 2014: Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire Journal of Acquired Immune Deficiency Syndromes 66(3): 294-302
Bannister, W.P.; Ruiz, L.; Loveday, C.; Vella, S.; Zilmer, K.; Kjaer, J.; Knysz, B.; Phillips, A.N.; Mocroft, A. 2006: HIV-1 subtypes and response to combination antiretroviral therapy in Europe Antiviral Therapy 11(6): 707-715
Cervia, J.S. 2016: Addressing the Needs of Youth With HIV Infection in the Era of Combination Antiretroviral Therapy Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 62(7): 947
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Rossi, S.M.G.d.; Maluf, E.C.P.; Carvalho, D.S.; Ribeiro, C.E.L.; Battaglin, C.R.P. 2012: Impact of antiretroviral therapy under different treatment regimens Revista Panamericana de Salud Publica 32(2): 117-123
Williams, B.G.; Lima, V.; Gouws, E. 2011: Modelling the impact of antiretroviral therapy on the epidemic of HIV Current HIV Research 9(6): 367-382
Madi, D.; Gupta, P.; Achappa, B.; Bhaskaran, U.; Ramapuram, J.T.; Rao, S.; Mahalingam, S. 2015: HIV Status Disclosure Among people Living with HIV in the Era of Combination Antiretroviral Therapy (cART) Journal of Clinical and Diagnostic Research: Jcdr 9(8): Oc14-Oc16
Nanda, K.; Amaral, E.; Hays, M.; Viscola, M.A.M.; Mehta, N.; Bahamondes, L. 2008: Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy Fertility and Sterility 90(4): 965-971
Eholié, S.P.; Tanon, K.A.; Folquet-Amorissani, M.; Ouattara, I.; Aba, Y.T.; Traoré-Ettiegne, V.; Kakou, A.R.; Aoussi, E.; Anglaret, X.; Bissagnéné, E. 2009: Impact of access to antiretroviral therapy in Côte d'Ivoire Medecine Tropicale: Revue du Corps de Sante Colonial 69(5): 520-524
Thienemann, F.; Sliwa, K.; Rockstroh, J.ür.K. 2013: HIV and the heart: the impact of antiretroviral therapy: a global perspective European Heart Journal 34(46): 3538-3546
Eholié, S.P.; Tanon, K.A.; Folquet-Amorissani, M.; Ouattara, I.; Aba, Y.T.; Traoré-Ettiegne, V.; Kakou, A.R.; Aoussi, E.; Anglaret, X.; Bissagnéné, E. 2009: Impact of access to antiretroviral therapy in Côte d'Ivoire Medecine Tropicale: Revue du Corps de Sante Colonial 69(5): 520-524
2001: Acceptance of antiretroviral therapy. HIV-infected patients assess convenient triple combination MMWFortschrittederMedizin 143(35-36): 56
McMenamin, J.; Allardice, G.; Goldberg, D.; Parpia, T.; Raab, G.; Parpira, T. 1998: Antiretroviral combination therapy and HIV infection. Such treatment improved CD4 counts in Scottish patients Bmj 317(7162): 887
Sempa, J.; Ssennono, M.; Kuznik, A.; Lamorde, M.; Sowinski, S.; Semeere, A.; Hermans, S.; Castelnuovo, B.; Manabe, Y.C. 2012: Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda Bmc Public Health 12: 736